These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 32155982)
1. Neutrophil-To-Lymphocyte and Platelet-To-Lymphocyte Ratios as Prognostic Markers of Survival in Patients with Head and Neck Tumours-Results of a Retrospective Multicentric Study. Szilasi Z; Jósa V; Zrubka Z; Mezei T; Vass T; Merkel K; Helfferich F; Baranyai Z Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32155982 [TBL] [Abstract][Full Text] [Related]
2. Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation. Bojaxhiu B; Templeton AJ; Elicin O; Shelan M; Zaugg K; Walser M; Giger R; Aebersold DM; Dal Pra A Radiat Oncol; 2018 Nov; 13(1):216. PubMed ID: 30400969 [TBL] [Abstract][Full Text] [Related]
3. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma]. Wu F; Wu LL; Zhu LX Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030 [No Abstract] [Full Text] [Related]
4. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of preoperative neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in patients with gallbladder carcinoma. Zhang Y; Jiang C; Li J; Sun J; Qu X Clin Transl Oncol; 2015 Oct; 17(10):810-8. PubMed ID: 26077119 [TBL] [Abstract][Full Text] [Related]
6. Systemic immune response in squamous cell carcinoma of the head and neck: a comparative concordance index analysis. Tham T; Wotman M; Chung C; Ahn S; Dupuis H; Gliagias V; Movsesova T; Kraus D; Costantino P Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2913-2922. PubMed ID: 31312922 [TBL] [Abstract][Full Text] [Related]
7. Pretreatment count of peripheral neutrophils, monocytes, and lymphocytes as independent prognostic factor in patients with head and neck cancer. Valero C; Pardo L; López M; García J; Camacho M; Quer M; León X Head Neck; 2017 Feb; 39(2):219-226. PubMed ID: 27534525 [TBL] [Abstract][Full Text] [Related]
8. High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis. Yang L; Huang Y; Zhou L; Dai Y; Hu G Head Neck; 2019 May; 41(5):1525-1535. PubMed ID: 30597654 [TBL] [Abstract][Full Text] [Related]
9. Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors. Goh BK; Chok AY; Allen JC; Quek R; Teo MC; Chow PK; Chung AY; Ong HS; Wong WK Surgery; 2016 Apr; 159(4):1146-56. PubMed ID: 26688506 [TBL] [Abstract][Full Text] [Related]
10. Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation? Solmaz Medeni S; Acar C; Olgun A; Acar A; Seyhanlı A; Taskıran E; Sevindik OG; Alacacıoglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH Clin Transplant; 2018 Sep; 32(9):e13359. PubMed ID: 30053318 [TBL] [Abstract][Full Text] [Related]
11. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab? Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M J BUON; 2015; 20(3):714-22. PubMed ID: 26214622 [TBL] [Abstract][Full Text] [Related]
12. The Role of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio, and Platelets in the Prognosis of Metastatic Renal Cell Carcinoma. Huszno J; Kolosza Z; Mrochem-Kwarciak J; Rutkowski T; Skladowski K Oncology; 2019; 97(1):7-17. PubMed ID: 31048577 [TBL] [Abstract][Full Text] [Related]
13. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer? Deng M; Ma X; Liang X; Zhu C; Wang M Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461 [TBL] [Abstract][Full Text] [Related]
14. Combination of peripheral neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio is predictive of pathological complete response after neoadjuvant chemotherapy in breast cancer patients. Graziano V; Grassadonia A; Iezzi L; Vici P; Pizzuti L; Barba M; Quinzii A; Camplese A; Di Marino P; Peri M; Veschi S; Alberti S; Gamucci T; Di Gioacchino M; De Tursi M; Natoli C; Tinari N Breast; 2019 Apr; 44():33-38. PubMed ID: 30611095 [TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio: Prognostic indicator for head and neck squamous cell carcinoma. Rosculet N; Zhou XC; Ha P; Tang M; Levine MA; Neuner G; Califano J Head Neck; 2017 Apr; 39(4):662-667. PubMed ID: 28075517 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in giant cell tumor of the extremities. Chen Z; Zhao G; Chen F; Xia J; Jiang L BMC Cancer; 2019 Apr; 19(1):329. PubMed ID: 30961549 [TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab. Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390 [TBL] [Abstract][Full Text] [Related]
18. Neutrophil-lymphocyte and platelet-lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma. Bagante F; Tran TB; Postlewait LM; Maithel SK; Wang TS; Evans DB; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM J Surg Oncol; 2015 Aug; 112(2):164-72. PubMed ID: 26234285 [TBL] [Abstract][Full Text] [Related]
19. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer? Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926 [TBL] [Abstract][Full Text] [Related]
20. Are Inflammatory Markers Significant Prognostic Factors for Head and Neck Cancer Patients? Abelardo E; Davies G; Kamhieh Y; Prabhu V ORL J Otorhinolaryngol Relat Spec; 2020; 82(5):235-244. PubMed ID: 32396900 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]